“Colistin As A Good Monotherapy to Restrain the Pathogenicity of Acinetobacter Baumannii In Vivo and In Vitro”. Baghdad Science Journal, vol. 19, no. 2, Apr. 2022, p. 0255, https://doi.org/10.21123/bsj.2022.19.2.0255.